Patent details
300533 Product Name: Dapoxetine, alsmede farmaceutisch aanvaardbare zouten daarvan.
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic Information
- Publication number:
- 300533
- Type:
- Certificate
- SPC Type:
- Medical
- Basic Patent Number:
- EP1225881
- Status:
- Expired Art. 14 (a) of the EC Regulations
- Application number:
- 300533
- Procedural language:
- Dutch
- First Applicant Residence Country:
Marketing Authorization
1
- Marketing Authorization Number:
- 24353 - 24354
- Marketing Authorization Type:
- EEA
- Marketing Authorization Date:
- 05/02/2009
- Marketing Authorization Country:
- Finland (FI)
2
- Marketing Authorization Number:
- RVG108199 - 200
- Marketing Authorization Type:
- National/EU
- Marketing Authorization Date:
- 21/02/2012
- Marketing Authorization Country:
- Netherlands (NL)
Dates
- Filing date:
- 14/06/2012
- First Marketing Authorization date:
- 05/02/2009
- Grant date:
- 08/11/2012
- Activation date:
- 22/08/2020
- Lapsed By Non Payment Annual Fee Date:
- Renunciation Date:
- NullificationDate:
- Registration date:
- 14/06/2012
- SPC/SPC Extension Expiration Date:
- 04/02/2024
- Lapsed By Expiration Date:
- 05/02/2024
- Withdrawal date:
- Revocation Date:
- Invalidity Date:
- Withdrawal Market Authorization Date:
- Refusal Date:
Applicant/holder
- From:
- 02/01/2020
- Name:
- Allergan Sales, LLC
- Address:
- 2525 Dupont Drive, 92612, Irvine, California, United States of America (US)
Historical Applicant/holder
- From:
- 14/06/2012
- To:
- 02/01/2020
- Name:
- APBI Holdings, LLC
- Address:
- 3151 South 17th Street, 28412, Wilmington, North Carolina, United States of America (US)
Agent
- Name:
- ir. H.A. Witmans c.s.
- From:
- 14/06/2012
- Address:
- V.O. Postbus 87930, 2508 DH, Den Haag, Netherlands (NL)
- To:
Publication
Bulletin
1
- Bulletin Heading:
- VRV
- Journal edition number:
- 06/24
- Publication date:
- 07/02/2024
- Description:
- Lapse or annulment
2
- Bulletin Heading:
- SPC
- Journal edition number:
- 35/20
- Publication date:
- 26/08/2020
- Description:
- Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
3
- Bulletin Heading:
- CO
- Journal edition number:
- 02/20
- Publication date:
- 13/01/2020
- Description:
- Changes in the Netherlands Patent Register
4
- Bulletin Heading:
- SPC
- Journal edition number:
- 2012/47
- Publication date:
- 21/11/2012
- Description:
- Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
5
- Bulletin Heading:
- SPC
- Journal edition number:
- 2012/26
- Publication date:
- 27/06/2012
- Description:
- Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
Deed
Change of owner(s)
- Change Kind/ Decision Type:
- Merge
- Deed Number:
- RC202000010A
- Date Registered:
- 02/01/2020
- License Effective Date:
- License Expiration Date:
- Scope of License:
- Deed Filer:
- ir. H.A. Witmans c.s.
- Journal Edition Number:
- Text:
- Deed Status:
- Country Code:
- Updated License Number:
- Terminated License Number:
Added Owner(s)
- Name:
- Allergan Sales, LLC
- Address:
- 2525 Dupont Drive, 92612, Irvine, California, United States of America (US)
Changed Pledgee
- Name:
- Address:
Removed Usufructuary
- Name:
- Address:
Added Usufructuary
- Name:
- Address:
Changed Usufructuary
- Name:
- Address:
Annual Fee
- Annual Fee(s) Due Date:
- Annual Fee Number:
- Last Annual Payment Date:
- 19/06/2023
- Last Annual Fee Paid Number:
- 24
- Last Annual Fee Paid Amount:
- 2200 Euro
- Payer:
- Master Data Center
| Filing date | Document type | Document Description | Number of pages | File Type | ||
|---|---|---|---|---|---|---|
| 08/11/2012 | Outgoing Correspondence | Outgoing Letter | 1 | /3/3/5/0/0/0400300533/docs/300533_1_outgoingcorrespondence20121108.pdf | ||
| 08/11/2012 | SPC Documents | Certificate SPC | 1 | /3/3/5/0/0/0400300533/docs/300533_5_supplprotectioncertificate20200921021121625.pdf | ||
| 16/10/2012 | Incoming Correspondence Paper | Accompanying letter incoming document | 1 | /3/3/5/0/0/0400300533/docs/300533_8_incomingcorrespondencepaper20210310033806725.pdf | ||
| 31/07/2012 | Outgoing Correspondence | Outgoing Letter | 3 | /3/3/5/0/0/0400300533/docs/300533_4_outgoingcorrespondence20120731.pdf | ||
| 19/06/2012 | Outgoing Correspondence | Outgoing Letter | 1 | /3/3/5/0/0/0400300533/docs/300533_2_outgoingcorrespondence20120619.pdf | ||
| 14/06/2012 | Application Form | First filed application form | 2 | /3/3/5/0/0/0400300533/docs/300533_0_applicationform20120614.pdf | ||
| 14/06/2012 | SPC Documents | Marketing Authorization SPC | 2 | /3/3/5/0/0/0400300533/docs/300533_3_supplprotectioncertificate20200921020532694.pdf | ||
| 14/06/2012 | SPC Documents | Marketing Authorization SPC | 2 | /3/3/5/0/0/0400300533/docs/300533_6_supplprotectioncertificate20200921020741229.pdf | ||
| 14/06/2012 | SPC Documents | Annex SPC | 1 | /3/3/5/0/0/0400300533/docs/300533_7_supplprotectioncertificate20200921020342142.pdf |